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1. Introduction 
 
Infants are the people under the age of 12 months and infant formula is the product presented 
as mothers’ milk substitute, which satisfies the nutritional requirements of infants up to four 
to six months of age (Australian Government, 2000). Mothers’ milk is the best food for 
adequate growth and development of infants as it contains a balance of essential nutrients and 
specific bioactive components such as growth factors, immune factors, enzymes etc. that are 
explicitly available only in mothers’ milk (Alles, Scholtens, and Bindels, 2004). Infant 
formula forms a substitute only when breast milk is inadequate or ceases for some reason. At 
present, due to the advances in food technology and engineering, the main targets of current 
infant formula have been supposedly met from the point of view of safety for infants and the 
composition in macro-nutrients (protein, fat, and carbohydrates) and micro-nutrients 
(vitamins and minerals) comparable to mothers’ milk (Hernell, 2011). However, there can be 
differences in outcomes in growth and development patterns between breast-fed infants and 
formula-fed infants in both the short and long term. For instance, formula-fed infants gain 
weight faster and have more body fat from 3 months of age; have different gut microbiota; 
and also have higher concentration of serum amino acids, insulin, blood urea nitrogen 
compared to breast-fed infants. These factors are related to higher risk of obesity, diabetes, 
and cardiovascular disease (Lönnerdal, 2014). Ideally, both breast-fed and formula-fed 
infants should show similar growth and development patterns (Lönnerdal, 2014). To achieve 
this goal, modifications of nutrients in infant formula with clinical trials are being carried out 
(Lönnerdal, 2014). Alongside this, there is a need to study the digestibility of various 
ingredients supplemented in infant formula to better understand the degradation mechanism 
of these components as well as the bio-accessibility of the digested nutrients in the 
gastrointestinal tract. Application of in vitro models to simulate digestion through the 
gastrointestinal tract has become widely more popular than obtaining data from in vivo 
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experiments due to no ethical restrictions, low cost, and less time requirements. The in vitro 
models help observe the digestibility, structural changes, and the release of nutrients under 
simulated gastrointestinal digestion (Hur, Lim, Decker, and McClements, 2011).  
 
2. Digestion in infants with comparison to adults  
 
Mothers’ milk and infant formula, the main food for infants, are a rich source of proteins, fats 
and carbohydrates. The digestion of these ingredients provides the essential nutrients for the 
growth and development of babies. The knowledge of infant gastrointestinal function plays 
an important role in infant feeding application and has advanced rapidly over the past few 
decades (Friedt and Welsch, 2013; Lebenthal, Lee, and Heitlinger, 1983).  
 
Digestion process in infants aged between 0-6 months who exclusively consume liquid milk 
does not happen at oral phase due to the very short transit time through mouth, pharynx and 
oesophagus (10-15 seconds) (Arvedson and Brodsky 2002). Therefore, infant digestion of 
macronutrients mainly occur in gastric and intestinal phases. Although it is clear that the 
gastrointestinal system is quite mature in full-term newborns (newborns are human infants in 
the first 28 days of life, WHO), the availability of some digestive enzymes, their 
concentration, and gastric pH are different between infants and adults (Bourlieu et al., 2014). 
The digestive enzymes are salivary amylase secreted by salivary gland, pepsin and gastric 
lipase secreted by human gastric mucosa, pancreatic enzymes, and brush border mucosal 
enzymes (Hamosh, 1996; Moreau, Laugier, Gargouri, Ferrato, and Verger, 1988). The 
pancreatic enzymes contain proteases (trypsin, chymotrypsins, etalastase, carboxypeptidases), 
lipases (colipase-dependent lipase, carboxyester lipase, pancreatic lipase related proteins, bile 
salt dependent lipase). Brush border mucosal enzymes contain lactase, glucoamylase, sucrase, 
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isomaltase which hydrolyse carbohydrates (Hamosh, 1996). Table 1 summarises and 
compares the activities of the digestive enzymes found in the gastrointestinal tract of both 
adults and infants. 
 
Infant gastric pH is less acidic compared to adults. It has been reported that gastric pH in pre-
term infant varied from 3.2 to 3.5 before feeding and raised to 6.0-6.5 immediately after 
having a meal (Bourlieu et al., 2014). In an earlier study Nagita et al. (1996) observed a 
gastric pH of 3.0-4.0 in newborns (under 28 days old) and 1.5-3.0 in infants (under 12 months 
old) during fasting. Figure 1 shows that the pH in infant’s stomach increases from 3.5 to 6.4 
before and after 30 minutes of feeding with mothers’ milk and then decreases to above pH 3 
after 180 min of gastric digestion (Roman et al., 2007; Mason, 1962). Cavell (1983) also 
observed a decrease in pH of infant gastric content 6.0 (after 30 minutes of feeding) and 
further decreased to pH 5.2 (after two hours of feeding). The corresponding pH figures in 
adult stomach is 1.5-1.8 (Mitchell, McClure, and Tubman, 2001; Shani-Levi, Levi-Tal, and 
Lesmes, 2013). Thus based on the above study it is clear that after two hours of feeding, 
gastric pH in the infant stomach remains between 4-5, while the pH for adults is lower than 2 
which has also been reported by Li-Chan and Nakai, (1989). Table 2 summarises the pH 
change after one hour of feeding for infants of different ages. In the intestinal phase, both 
adults and infants have similar pH in the small intestine (Andrea, and Nikoletta, 2010).  
 
2.1. Digestion of proteins in infants  
 
Digestion of proteins in infants involve proteases in the stomach, luminal proteases and brush 
border peptidases in the small intestine (Dallas, Underwood, Zivkovic, and German, 2012). 
The gastric and intestinal digestion of proteins is described in the following sections. 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
Gastric proteolysis 
 
Pepsin is the protease responsible for digestion of protein in the stomach at an optimal pH 2. 
In full-term-infants, the high gastric pH and low output of pepsin restricts digestion of milk 
protein in the infant stomach compared to that in adults (Mason, 1962). The infants’ gastric 
pH is higher than the optimal pH required for secretion of the pepsin enzyme (Hamosh, 1996) 
and this results in minimal protein hydrolysis in the stomach of babies below 3 months of age 
because of very low pepsin secretion and high gastric pH, (Agunod, Yamaguchi, Lopez, and 
Glass, 1969). Berfenstam, Jagenburg, and Mellander (1955) also detected only traces of 
hydrolysed protein in the stomach of newborn infants. Conversely, full-term-infants from 3 
months of age can have a level of pepsin similar to that of older children and adults while 
pre-term infants have only 50% of the pepsin level found in full-term infants (DiPalma et al., 
1991).  
 
In stomach of newborns within 6-8 hours of postpartum, Henschel, Newport, and Parmar 
(1987) detected a protease highly hydrolysed milk protein that resembles chymosin found in 
calf. However, this protease disappears from the gastric fluid at 10 days of postpartum, and is 
not found in adult gastric fluid (Dallas et al., 2012). In their researches, Holton et al. (2014) 
and Dallas et al. (2012, 2014) used peptidomic analysis to study in vivo proteolysis of 
mother’s milk in infant stomach. They compared the activity of protease in mother’s milk 
before and after 2 hours of ingestion and detected a significantly higher level of peptides in 
digested samples than in mother’s milk. It is likely that proteases from mother’s milk 
continue to be active in infant stomach and is responsible for protein hydrolysis not the 
gastric proteases secreted in the infant stomach. To understand gastric protein hydrolysis, 
more thorough studies requires to be done.   
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Intestinal proteolysis 
 
Following digestion in the stomach by pepsin, the protein is further hydrolysed into peptides 
by pancreatic proteases (trypsin, α-chymotrypsin, elastase, peptidases, carboxypeptidases A, 
and carboxypeptidases B) in the intestine (Boisen and Eggum, 1991). The peptides are further 
broken down by peptidases in the intestinal brush border. Trypsin is the most vital digestive 
proteases and accounts for up to 20% of the protein in pancreatic fluids (Hamosh, 1996). 
Borgstrom, Lindquist, and Lundh (1960) suggested both pre-term and full-term infants have 
similar concentration of trypsin as in adults, while the levels of chymotrypsins and 
carboxypeptidases B just account for about 10% to 60% of the activity present in adults 
(Lebenthal and Lee, 1980a).  
 
It is widely accepted that brush border and cytosolic peptidases (excluding amino-peptidases) 
completely hydrolyse peptides into amino acids, even in premature infants (Auricchio, 
Stellato, and De Vizia, 1981). As per Lebenthal, Lee & Heitlinger (1983) (cited in Hiranta & 
Matusuo, 1969), ten-day-old babies can absolutely digest and absorb 1.3% cow milk protein 
and four to six-month-old babies can absolutely digest and absorb 2.5% cow milk protein. 
  
Digestion of lipids in infants 
 
Lipids account for around half of the total energy content in breast milk and formulas and 
contain n-6 and n-3 fatty acids such as linoleic acid (C18:2, n-6) and α-linoleic acid (C18:3, 
n-3) crucial for brain and eye development of infants (Hermoso et al., 2010, Joeckel and 
Phillips, 2009). They are the transporters of essential fat-soluble vitamins. Thus, adequate 
digestion and absorption of dietary fats in infants is paramount. The major difference in lipid 
digestion and absorption between infants and adults is the lipid intake per kilogram of 
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bodyweight, which is much higher (three to five times) in infants than adults (Andersson, 
Hernell, Bläckberg, Fält, and Lindquist, 2011). Also, the activity and function of digestive 
lipases varies between infants and adults.  
 
Gastric lipolysis 
 
Gastric lipolysis plays a more important role in fat digestion in infants than in adults. Enzyme 
gastric lipase digests the milk fat in the infant diet. It is well known that both lingual lipase 
and gastric lipase are present in rodent infants (Hamosh, 1990 and Hamosh, 1994). However, 
so far there is no evidence of existence of lingual lipase in humans (N'Goma et al., 2012; 
Moreau et al., 1988). Gastric lipase is active over a wide range of pH levels (1.5-7.0), does 
not require bile salts as the cofactor, is not inhibited by milk fat globule membranes (Ville, 
Carrière, Renou, Laugier, 2002; Hamosh, 1996; Hernell et al., 1988) and is capable of 
hydrolysing the triglyceride within milk fat globules (Bourlieu et al., 2015; Bernbäck, 
Bläckberg, and Hernell 1990; Plucinski, Hamosh; Hamosh, 1979; Cohen, Morgan, and 
Hofmann, 1971). Conversely pancreatic triglyceride lipase and bile salt stimulated lipase 
cannot hydrolyse the core of triglycerides because of their inability to penetrate into milk fat 
globules (Roman et al., 2007; Cohen, Morgan, & Hofmann, 1971). Thus, gastric lipase is able 
to act properly in the infant stomach. Besides, fatty acids produced in gastric phase 
encourages the activity of pancreatic lipase due to the better interface between fat globules 
and the aqueous environment (Bernbäck, Bläckberg, and Hernell, 1989). Thus, fat hydrolysis 
in the stomach may quantitatively be more important for infants than in adults (Carey, Small, 
and Bliss, 1983; Hamosh et al., 1981; Murphy and Signer, 1974).  
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It has been shown that the level of gastric lipase in infants is similar to the level found in 
adults (Sarles Moreau, and Verger, 1992). Commare and Tappenden (2007) suggested a rise 
in gastric lipase activity from 26 and 35 weeks of gestation, which then reaches adult levels 
when babies are born full term. Some studies (Armand et al., 1996; Armand et al., 1995) also 
reported gastric lipase activity in full-term infants was much higher than in adults, with four-
week-old infants having gastric lipase activity 50% higher than adults’ levels. DiPalma et al. 
(1991) examined the activity of gastric lipase in humans from different age groups (5-19 
months, 2-4 years, 6-10 years, 11-13 years, and 15-26 years). They observed the gastric 
lipase activity to be in the range of 1.8-5.3 U/mg protein (1U is 1 µmol oleic acid released 
from triolein per minute), and no significant difference in the lipase activity between the 
studied age groups. The high level of gastric lipase may compensate for the low amount of 
pancreatic lipases and explains why infants can consume a high dietary fat (Armand et al 
1996, Hamosh, 2006). Armand et al (1996) also observed rapid gastric lipolysis of mother’s 
milk compared to infant formula due to the significant amount of lipase present in mothers’ 
milk. 
 
In adults, gastric lipase hydrolyses 10-25% of lipids in the stomach and the remainder fat 
hydrolysis takes place in the duodenum with the help of pancreatic lipase (Gallier, and Singh, 
2012; Hamosh, 1990). In healthy infants, due to the clinical invasive procedures such as the 
employment of nasogastric and nasoduodenal tubes or the drawing of blood samples, very 
limited data about physical digestion is known so far. Meanwhile, preterm infants are usually 
fed via a tube that allows to collect the samples (Abrahamse et al., 2012). It has been reported 
that up to 25-60% of fat digestion may happen in the stomach of animal infants depending 
upon species (Abrahamse et al., 2012; Hamosh, 2006). In preterm infants, gastric lipolysis 
accounted for 25% of fat digestion for mother milk and 14% for infant formula (Ruegg and 
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Blanc, 1982). Similar results have been reported by Hamosh, Sivasubramanian, Salzman-
Mann, and Hamosh, (1978) and Hernell et al., (1988) who observed a significant hydrolysis 
of dietary fat in the preterm infant stomach. 
 
Substrate selectivity is also an important function of gastric lipase. Gastric lipase has high 
specificity to sn-3 position of the triglycerides (Hamosh, 1996; Hamosh, Iverson, Kirk, and 
Hamosh, 1994). As a result, long-chain polyunsaturated fatty acids in mother milk and short 
to medium chain fatty acids in bovine milk are efficiently released in the infant stomach 
because they are primarily settled at sn-3 position (Hamosh, 2006). However, an in vivo 
digestion study by Roman et al. (2007) with infant formula enriched with 25% of medium 
chain triglycerides (octanoic and decanoic acids), shows the profile of released fatty acids 
was dominated by palmitic acids and oleic acids, not the medium chain ones. This suggests 
gastric lipase mainly hydrolyses long chain fatty acids as this enzyme has a higher affinity 
towards sn-3 position. 
 
The other important function of gastric lipase is working in conjunction with pancreatic 
lipases in the duodenum (Carriere, Barrowman, Verger, and Laugier, 1993 and Bernbäck et 
al., 1989). Gastric lipase can penetrate into the core of milk fat globules (while pancreatic 
triglyceride lipase and bile salt stimulated lipase cannot) due to its hydrophobic nature and 
inability to hydrolyse the acyl bond of phospholipids (Bourlieu et al., 2015). Hence, 
pancreatic triglyceride lipase and bile salt stimulated lipase uses partially hydrolysed milk fat 
globules from the stomach as the substrate to perform its activity (Hamosh, 1996; Bernbäck, 
Bläckberg, & Hernell, 1990). 
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Intestinal lipolysis 
 
Pancreatic triglyceride lipase (PTL), pancreatic lipase-related to protein 2 (PLRP 2), and bile 
salt-stimulated lipase (BSSL) are the principle lipases involved in the duodenal digestion of 
lipids. Pancreatic lipase-related to protein 1 (PLRP 1) was detected in small intestine of 
human newborns, but has no lipase activity (Berton, Sebban‐Kreuzer, Rouvellac, Lopez, and 
Crenon, 2009; Roussel et al., 1998). Lipids need to be emulsified by bile salts first to enable 
hydrolysis by pancreatic lipases.  
 
The activity of pancreatic lipases and the concentration of bile salt in infants are very low 
(Lebenthal et al., 1983; Lindquist and Hernell, 2010) compared to adults. The concentration 
of pancreatic lipase and bile salts in mature infants are approximately 5-10% and 50% of 
adults’ figures, respectively (Lebenthal et al., 1983), while the corresponding for preterm 
infants were much lower (Hernell, Blackberg, and Bernback, 1988; Lebenthal et al., 1983). 
 
While in adults, PTL is the principle lipolytic enzyme in the small intestine, PLRP2 and 
BSSL are predominant during lipid digestion in infants (Andersson et al., 2011; Lindquist & 
Hernell, 2010). The exact activity of PLRP2 and bile salt-stimulated lipase in infants is still 
not clear (Andersson et al., 2011). It is believed breast-fed infants are able to digest lipids in 
the small intestine better than formula-fed infants because of significant activity of BSSL 
present in mothers’ milk (Hamosh, 1996; Formon, Ziegler, Thomas, Jensen, and Filer, 1970). 
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2.2. Digestion of carbohydrates in infants  
 
Carbohydrate intake accounts for 35-55% of total energy in the infant diet. There are three 
stages of carbohydrate consumption in the early stages of human life starting from newborn 
to childhood. In the first stage of life, lactose from mothers’ milk or formulas is the main 
source of carbohydrates without any solid food. The next stage introduces the presence of 
different polysaccharides such as maltodextrin, carob bean gum, guar gum, xanthan gum that 
are thickening agents added to mother milk and infant formula (Cichero, Nicholson, and 
September, 2013). The last phase is dominated by polysaccharides with solid food (Lebenthal 
et al., 1983).  
 
Lactose and sucrose are hydrolysed by lactase and sucrase enzymes into monosaccharide 
components at birth for full-term infants. Hence, full-term infants are able to digest lactose 
and sucrose that comes from mothers’ milk or infant formulas during the neonatal period. 
However, a low lactase activity is found in pre-term babies born at 28-34 weeks of gestation 
while maltase and isomaltase are detected at high levels at that time (70% level of full term). 
Consequently, infants born at 34 weeks of gestation can well tolerate maltose, sucrose, and 
isomaltose but not lactose (Lebenthal et al., 1983). However, clinical lactose intolerance is 
uncommon in preterm infants despite low lactase levels (Patole, 2013). 
 
Polysaccharides need a group of enzymes to complete digestion. The digestion of starch 
depends on salivary amylase, pancreatic amylase, glucoamylase, maltase, and isomaltase for 
complete digestion. The salivary and pancreatic amylase are classified as α-amylase. Very 
low levels of α-amylase are found in the saliva of infants (within the first month), which is 
less than 25% the amount found in adults. However, due to the lack of pancreatic amylase, 
salivary amylase contributes to a significant amount of starch digestion in infants (Sibley, 
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2004). Lebenthal et al. (1983) have found evidence of very low or no α-amylase activity in 
the duodenal fluid of babies less than 4 months of age. For breast-fed infants, there is a 
significant supply of α-amylase from mother milk. In mother milk, the highest activity of α-
amylase is in colostrum and declines rapidly during the course of lactation (Dewit, Dibba, 
and Prentice, 1990).  
 
Glucoamylase (or amyloglucosidase) is a brush border enzyme that can digest starch directly 
to glucose. In the small intestinal mucosa of newborns and infants, glucoamylase activity has 
been reported to be above 50% that of adults (Lebenthal et al, 1983). Therefore, although 
pancreatic amylase is absent in newborn babies, they can digest a reasonable amount of 
starch because glucoamylase becomes an alternate enzyme for starch digestion in infants 
(Lebenthal and Lee, 1980b). Lee, Werlin, Trost, and Struve (2004) examined the activity of 
enzymes responsible for carbohydrate hydrolysis in 214 subjects aged from 1 month to 20 
years including 11 infants and observed no significant difference with age in the activity of 
these enzymes. 
  
3. Difference in composition between mothers’ milk and infant formula and their 
digestibility   
 
Mothers’ milk is the most complete food for human infants at least up to the age of 6 months 
(Agostoni et al., 2008; Eidelman and Feldman-Winter, 2005; World Health Organization, 
2003). Mothers’ milk provides the ideal nourishment for infants’ growth and development 
because of the well-balanced nutrition, growth factors, and immune components that have 
beneficial effects on infants’ digestion and immune system (Hernell, 2011; Agostoni et al., 
2009; Alles, Scholtens, & Bindels, 2004). Table 3 provides a comparison of the major 
nutrients, their amount, and function present in mothers’ milk and bovine milk. 
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Although the composition of mothers’ milk has been reported as being variable during 
lactation and among mothers (Flack and Shaw, 2003; Goedhart and Bindels, 1994), it is still 
considered as a guide to establish the composition of infant formulas (O’Callaghan, 
O’Mahony, Ramanujam, & Burgher, 2011; Floris, Lambers, Alting, and Kiers, 2010; Aggett 
et al., 2001; Ben, 2008). Most of the infant formulas are based on cow’s milk and a minority 
use soy protein isolate as a protein source. The differences in composition between human 
milk and bovine milk led to the modification of the infant formula contents, to be closer to 
human milk as much as possible (Goedhart & Bindels, 1994). 
 
The sections below describe the main components of mothers’ milk: proteins, fats and 
carbohydrates that is taken into consideration while designing infant formulas. 
 
3.1. Proteins 
 
Mothers’ milk contains a wide range of proteins that play unique roles in the growth and 
development of infants. Many of them are well digested to provide a balanced source of 
amino acids, others take responsibility for assisting nutrient digestion and absorption (α-
amylase, bile salt simulated lipase, lactoferrin, β-casein, α-lactalbumin), protecting newborns 
from illness and bacterial infection (immunoglobulins, lactoferrin, lysozyme, κ-casein, α-
lactalbumin, and lactoperoxidase) (Lönnerdal, 2003). 
 
It is well known that protein content in human milk is around 0.8-1.3 g/100 mL (Bosscher et 
al., 2000; Jensen, 1995), much lower than in cow milk that has about 3.4 g of protein/100 mL 
(Jensen, 1995). While the ratio between whey and casein in mature mothers’ milk is 60:40, 
the proportion in cow milk is about 20:80 (Hernell, 2011; Gurr, 1981). In addition, the 
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proportions of whey and casein subclasses between the two milks are very different and that 
is discussed in detail in the below sections.  
 
Whey protein  
 
(a) α-lactalbumin: α-lactalbumin is the main protein in human milk and accounts for 41% of 
whey and 17-28% of total protein. However, in bovine milk α-lactalbumin accounts for only 
3.0-3.5% of total protein (Heine, Klein, and Reeds, 1991; Gurr, 1981). Because in human 
milk, α-lactalbumin accounts for 63.2% of total essential amino acids with a high content of 
lysine and cysteine and a remarkably high content of tryptophan (5.9% of total amino acids), 
the problem with infant formulas based on cow milk is the low level of tryptophan and 
cysteine (Heine et al., 1991). This is the reason why the protein content in infant formula is 
adjusted to ≥ 15 g of protein/L compared to mother milk 9-11 g of protein/L to compensate 
for the difference in essential amino acids between mother milk and infant formula (Heine, 
Radke, Wutzke, Peters, & Kundt, 1996; Lien, 2003, Davis, Harris, Lien, Pramuk, and 
Trabulsi 2008). Therefore, infant formulas were supplemented with α-lactalbumin to improve 
protein quality, reduce total protein concentration, and make amino acid composition similar 
to that in mothers’ milk (Sandström, Lönnerdal, Graverholt, and Hernell, 2008; Heine et al., 
1991). α-lactalbumin concentration in current formulas is 0.14 g/100 mL and 0.22 g/100 mL 
for α-lactalbumin based infant formula (Lien, 2003). 
 
Some past researchers have reported limited digestion of α-lactalbumin in cow’s milk, human 
milk, and infant formula under simulated gastric digestion using human gastric juices or 
commercial porcine pepsin (Chatterton, Rasmussen, Heegaard, Sørensen, & Petersen, 2004; 
Sakai et al., 2000; Jakobsson, Lindberg, and Benediktsson, 1982). Jakobsson et al. (1982) 
observed that only 1 mg of α-lactalbumin as opposed to 30 mg of casein was digested under 
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the same condition at pH 4.5-5.0 (normal gastric pH of infants) or even pH 1.5-2.0 which is 
optimal for pepsin. Sakai et al. (2000) studied the in vitro gastric digestibility of α-
lactalbumin of commercial infant formula at pH 1.5-4.0. α-lactalbumin hydrolysed at pH 1.5-
2.5, but it was resistant to proteolysis at pH above 3.0. Similar results were obtained during 
human infants in vivo digestion study by Chatterton et al. (2004) with mothers’milk, and 
cow’s milk. Their inference was, α-lactalbumin significantly resists digestion, and it is likely 
that α-lactalbumin in both human and cow’s milk have the same in vitro digestibility pattern.  
 
However, it is likely that during in vivo digestion, α-lactalbumin is well digested into small 
peptides in the upper part of the gastrointestinal tract such as stomach and duodenum and 
then act as bioactive peptides in later part of the gastrointestinal tract (Lönnerdal, 2014). 
Davidson and Lönnerdal (1987) and Donovan, Atkinson, Whyte, and Lönnerdal (1989) 
observed that no intact α-lactalbumin was detected in stool samples of preterm and term 
infants fed on mothers’ milk. Heine, Radke, Wutzke, Peters, & Kundt (1996) also observed 
the similar content of plasma tryptophan (tryptophan is high proportion in α-lactalbumin) in 
infants fed on mothers’ and formula enriched with α-lactalbumin. In addition, Lien, Davis, 
Euler, and Multicentre Study Group (2004) reported that the growth rates and serum albumin 
content were comparable between the infants’ group feeding standard formula and enriched 
α-lactalbumin formula. The reason for the difference of α-lactalbumin digestibility in vitro 
and in vivo is possibly the full enzyme system in vivo as compared to in vitro conditions. 
 
(b) Lactoferrin: Lactoferrin is the second highest whey protein in mothers’ milk with an 
average amount of 1.4 mg/mL (O’Callaghan et al., 2011) and is considered to have more 
immune function than nutritional value. It plays an important role as an iron transport protein, 
mucosal proliferation stimulant and has antibacterial effect (Chierici and Vigi, 1994; Iyer and 
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Lönnerdal, 1993; Davidson & Lönnerdal, 1987). It is worth noting that both lactoferrin in 
mothers’ milk and cow milk are highly resistant to hydrolysis by proteinases (Lönnerdal, 
2014; Goedhart & Bindels, 1994). 
 
Because lactoferrin content in cow milk is very low, varying between 0.15 - 485.63 μg/mL 
(Adlerova, Bartoskova, and Faldyna, 2008), lactoferrin was the first supplement added to 
infant formula in 1986 (Ben, 2008; Tomita, Wakabayashi, Yamauchi, Teraguchi, and 
Hayasawa, 2002). Clinical studies indicate lactoferrin enriched formulas help infants increase 
haematocrits and reduce the incidence of respiratory illnesses (O’Callaghan et al., 2011). 
Therefore, the European Food Safety Authority recommended 0-6 month-old-infants could 
take 200 mg of lactoferrin per kg bodyweight or 1.2 g bovine lactoferrin per day without 
adverse effects (Tetens, 2012).  
 
However, it was reported that infant formula enriched with lactoferrin does not improve iron 
absorption because bovine lactoferrin is not recognized by human lactoferrin receptors (Aly, 
Ros, and Frontela , 2013; Jovani, Barbera, and Farré, 2003; Jovani, Barbera, and Farré, 
2001). In addition, due to the high cost of this ingredient and the difficulty in preserving the 
bioactive function of lactoferrin during infant formula production, the application of 
lactoferrin in commercial infant formulas are still limited (O’Callaghan et al., 2011).  
 
(c) β-lactoglobulin: β-lactoglobulin is the dominant whey protein in cow milk with 
approximately 50% of total bovine whey protein, but it is completely absent in human whey 
(Gurr, 1981). β-lactoglobulin is thought of as an allergen (Wal, 2004), and the disulphide (S-
S) bonds may be responsible for the allergic reaction (Matsumoto, 2011). Therefore, 
removing β-lactoglobulin from cow’s whey or using hydrolysed whey were suggested in 
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order to make infant formulas closer to mothers’ milk (Eugenia Lucena, Alvarez, Menéndez, 
Riera, and Alvarez, 2006; Floris et al., 2010). 
 
(d) Immunoglobulins: The main immunoglobulins in human milk are secretory IgA (sIgA), 
IgG1, IgG2 and IgM, in which sIgA makes up the largest proportion with over 90% in human 
milk, at around 0.1-0.2 g/100 mL. The highest concentration of sIgA is found in human 
colostrum with 0.9 g/100 mL (Lönnerdal, 2013; Goldman, Goldblum, Atkinson, and 
Lönnerdal, 1989; Harzer and Bindels, 1985). Human colostrum contains approximately 100-
fold higher concentration of immunoglobulins than that in cow milk (Floris, Lambers, Alting, 
& Kiers, 2010; Gurr, 1981). Immuglobulins play an important part in protecting the newborns 
against infections from intestinal tract diseases (Floris et al., 2010; Uruakpa, Ismond, and 
Akobundu, 2002; Xu, 1996).  
 
While sIgA is the dominant immunoglobulin in mothers’ milk, IgG1 is the major one in 
bovine milk. In spite of the difference in their structure, they seem to have the same function. 
Attempts have been made to elevate the concentration of immunoglobulins in infant formulas 
by adding isolated immunoglobulins from bovine’s milk. However, whether bovine 
colostrum is acceptable to be added to infant formulas is questionable. Some clinical studies 
showed that cow colostrum enriched formula is beneficial for defence from rotavirus 
(Davidson et al., 1989; Ebina et al., 1985) or necrotising enterocolitis resistance in preterm 
piglets (Moller et al., 2011). Recent studies suggested bovine colostrum may be a relevant 
alternative to mothers’ milk with preterm infants when mothers’ milk is not available (Jensen 
et al., 2013). However, other studies demonstrated contradictory results, for example, Turner 
and Kelsey (1993) concluded that bovine milk antibodies could prevent illnesses related to 
rotavirus but not rotavirus infection. Aunsholt et al. (2012) also reported that although bovine 
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colostrum has been shown to support intestinal development in the newborn pigs, diets 
including bovine colostrum, did not improve intestinal function in children from 13 to 169-
months of age.   
 
Caseins 
 
In human milk, β-casein is the main casein, making up over 70% of total casein (O’Callaghan 
et al., 2011), the remaining amount is for αs1-casein and κ-casein. αs2-casein is not present in 
mothers’ milk. In cow’s milk, both β-casein and αs1-casein are the predominant casein. The 
whey/casein ratio in human milk changes during the lactation course, from about 90:10 in the 
early lactation, 60:40 in mature milk, and 50:50 in the late lactation (Kunz and Lönnerdal, 
1992). However, in cow’s milk the whey/casein ratio is 80:20 in colostrum and around 20:80 
in mature milk (Zhang and Carpenter, 2013; Fomon, 1993).   
 
(a) β-casein: β-casein is a highly phosphorylated protein, that supplies nutrition and has 
bioactive function. When being broken down in the gastrointestinal tract, smaller casein 
phosphopeptides are formed which facilitate calcium and zinc absorption (Lönnerdal, 2013; 
Sato, Noguchi, and Naito, 1986). This may lead to the better absorption of calcium from 
mother’s milk which has a high percentage of β-casein than infant formula. Commercial β-
casein with high-purity is available, that may be substituted to increase this protein content in 
infant formulas. However, clinical studies related to β-casein enriched-formulas are still 
limited (O’Callaghan et al., 2011).  
 
β-casein was instantly and completely digested during the gastric phase of in vitro digestion 
models for adults (Astwood, Leach, and Fuchs, 1996; Fu, Abbott, and Hatzos, 2002; Pinto et 
al., 2014) but remained almost stable in infants’ model (Dupont et al., 2010b). A similar 
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profile of digested products was observed with in vitro digestion by commercial enzymes and 
by human fluids using SDS page but digestion with human fluids was quicker (Benedé et al., 
2014). 
 
(b) κ-casein: κ-casein is heavily glycosylated and is present in very small amounts in 
mothers’ milk. This casein subunit is considered to stimulate the growth of probiotic bacteria 
and inhibit the adhesion of bacteria to the gastric mucosa (López, 2007; Stromqvist et al., 
1995). 
(c) αs2-casein: Not present in mothers’ milk, and only present at a very small proportion in 
cow milk. 
 
Heat treatment during processing is also a factor that affects digestibility of milk proteins due 
to protein aggregation as well as the Maillard reaction that modifies protein structure. Dupont 
et al. (2010d) reported heat processing during milk powder manufacture causes caseins to 
aggregate thereby increases its resistance to in vitro digestion. Recent studies applied 
proteomic techniques to compare the modification to proteins during different heat treatment 
(Wada and Lönnerdal, 2014). It was found that lactulosyllysine, a Maillard reaction product 
is an indicator of digestibility, a high level corresponds to low protein digestibility as 
observed with in-can sterilized and UHT milk. This suggests heat treatment decreases protein 
digestibility (Wada & Lönnerdal, 2014). 
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Soy protein isolate 
 
Soybased infant formula contains protein from plant (soybean), used for babies suffering 
from galactosemia (cow’s milk protein intolerance) or lactose intolerance (Joeckel & Phillips, 
2009; Thompkinson and Kharb, 2007). However, proteins from soybean are not easy to 
digest due to the structure of soy protein and heat treatment effects. Anti-nutritional factors in 
legume such as proteases inhibitors, tannins or phytates are minimized in soybean products 
with proper technological treatments (Carbonaro, Maselli, & Nucara, 2012). Heat processing 
promotes aggregation of β-sheet structure in soy proteins that provides resistance to its 
digestion (Carbonaro, Maselli, & Nucara, 2014; Carbonaro et al, 2012). Other significant 
concern has been raised relating to the effect of phytoestrogenic isoflavone content in soy 
based infant formula on nutritional adequacy and sexual development during infancy and 
later life. Many researchers proved the safety of isoflavones and concluded that soy based 
infant formulas can be an option for term infants (Vandenplas, De Greef, Devreker, and 
Hauser, 2011; Badger et al., 2009; Perry et al., 2007; Merritt and Jenks, 2004; Strom et al., 
2001; Klein, 1998). Nowadays, soy based formulas have become prevalent, accounting for 
approximately 25% of infant formula sold in the United States and 13% in New Zealand 
(Agostoni et al., 2006; Klein, 1998; Lönnerdal, 1994).  
 
Not many studies have investigated the digestibility of soybased infant formula. However, 
there are suggestions to pre-treat soy protein isolate by proteases to increase the number of 
soy protein hydrolysates, which will improve soy protein digestibility. (Li, Zhu, Zhou, Peng, 
and Guo, 2013; El-Agamy, 2007; Terracciano, Isoardi, Arrigoni, Zoja, and Martelli, 2002). 
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3.2. Lipids 
 
Mothers’ milk contains 3.0-4.5% fat that constitutes the principle energy source, providing 
approximately 50% total energy for the growth of infants (Alles et al., 2004; Flack & Shaw, 
2003). Fat in mothers’ milk is comprised of 98% triglycerides , 1% phospholipids and 0.5% 
cholesterols and cholesterol esters (Lapillonne, Groh-Wargo, Lozano Gonzalez, and Uauy, 
2013; Picciano, 2001).  
 
The major differences between the lipid in humans’ milk and infant formulas are their content 
of long-chain polyunsaturated fatty acids (LCPUFAs) with 20-22 carbon atoms, which is 
crucial for structural component of cell membrane phospholipids of the central nervous 
system and retinal photoreceptors (Foundation, 1992). Therefore, LCPUFAs are essential for 
the retina and brain development, and the functional outcome of these (Bindels, 1992). Both 
n-3 and n-6 LCPUFAs are present in humans’ milk, which do not exist in infant formulas 
without supplements (O’Callaghan et al., 2011). Mothers’ milk supplies a rich source of the 
essential LCPUFAs such as linoleic acids (LA), α-linoleic acids (C18:3, n-3) (ALA), 
docosahexanenoic acid (C22:6, n-3) (DHA), AA (arachidonic acid, C20:4, n-6) and other 
LCPUFAs (Hermoso et al., 2010; Koletzko, Thiel, and Abiodun, 1992). The level of 
LCPUFAs in humans’ milk is inconsistent due to the dietary content undertaken by mothers 
(Thompkinson & Kharb, 2007) and LCPUFAs level is found much higher in colostrum than 
in mature milk (Renneberg and Skåra, 1992).  
 
In an attempt to formulate infant formula similar to mothers’ milk, many studies have worked 
on the influence of infant formulas enriched with DHA and AA on visual and cognitive 
development during infancy. However, there have been very inconsistent results from these 
studies. Some studies concluded that DHA and AA supplemented infant formulas may 
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improve the visual resolution of preterm and term infants (Koletzko et al., 2001; San 
Giovanni, Berkey, Dwyer, and Colditz, 2000). Also, adding DHA individually or in 
combination with AA resulted in similar levels of essential fatty acids in the red blood cells 
of breastfed infants, and this supplementation has significant effect on visual function in 
infants (Hoffman et al, 2000; Neumann, Simmer, and Gibson, 2000). However, Neumann et 
al. (2000) observed that infants fed on formulas supplemented with DHA and AA did not 
lead to any expected influence on visual evoked potential, mental development, and 
psychomotor development, while their breastfed counterparts had significantly higher 
corresponding indexes. A report by Lucas et al. (1999) advocated that there was no 
significant difference in cognitive development between infants feeding with or without 
enriched LCPUFAs. In contrast, Willatts, Forsyth, DiModugno, Varma, and Colvin (1998) 
concluded LCPUFAs could increase the intelligence of babies who received LCPUFAs 
elevated formula. 
 
In addition to the inconsistent impact of LCPUFAs enriched formula on infant development, 
it is widely known that full-term infants can synthesize LCPUFAs such as DHA and AA 
from precursors (Uauy, Mena, Wegher, Nieto, and Salem, 2000). Therefore, a question was 
raised: should LCPUFAs be added to infant formula or not? (Fanaro and Vigi, 2012; Ben, 
2008; Alles et al., 2004). However, according to Lauritzen, Hansen, Jorgensen, and 
Michaelsen (2001), the endogenous synthesis may not meet the infants’ demand of DHA and 
AA. In addition, the levels of DHA in plasma lipids, in red blood cell membrane 
phospholipids, and in cerebral cortex was significantly higher in infants fed on the DHA 
supplement as compared with the non-supplement DHA. This finding supports a strong 
rationale for adding LCPUFAs in infant formulas. Indeed, ALA, DHA and AA were 
recommended to be added to infant formulas, but individually DHA or AA supplement was 
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not recommended because these compounds need to work together (Abayomi, 2005). In 
addition, high consumption of ALA could lead to the rise of lipid peroxidation, product 
rancidification, and influence the stability of the formula (Koletzko et al., 2005). The 
recommended amount of LCPUFAs by European Commission (2003) and the Coordinated 
International Expert Group of European Society for Paediatric Gastroenterology, Hepatology 
and Nutrition (ESPGHAN) (Koletzko et al., 2005) is summarised in Table 4.  
 
Cow’s milk fat is not relevant for infant formulas because it contains more short-chain and 
saturated fatty acids (over 50% of milk fatty acids), and almost no LCPUFAs (Haug, 
Hostmark, and Harstad, 2007; Jensen, Ferris, Lammi-Keefe, and Henderson, 1990). Fat in 
cow’s milk also has limited absorption by newborns (Bindels, 1992). Therefore, vegetable 
oils are currently added to infant formulas.  
 
In term of digestibility, the fat content in breast milk is much more efficiently digested and 
absorbed than the fat in bovine milk. This is because not only does breast milk contain a 
significant amount of bile salt-simulated lipase, but also a high proportion (over 70%) of 
triglycerides with palmitic acid located at sn-2 position (Jensen, 1999; Lien, Yuhas, and 
Boyle, 1993). The 2-monoglycerides with palmitic acids at the sn-2 position are easier to 
absorb by infants than free fatty acids (Sidnell and Greenstreet, 2011; Thompkinson & 
Kharb, 2007). The triglyceride structure also strongly influences the fat absorption, the longer 
the chain and higher the saturation of the fatty acids, the less it is well absorbed (Tomarelli, 
Meyer, Weaber, and Bernhart, 1968), (Bracco, 1994).  
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The size of fat globules may have a significant effect on digestibility in infants. Michalski, 
Briard, Michel, Tasson, and Poulain (2005) observed a difference in the sizes of fat globules 
between mothers’ milk and infant formula. The droplets were much larger in colostrum 
(9μm) and  mature mother milk (4μm) compared to infant formulas (0.4μm). Some recent 
studies have reported, homogenised fat droplets were digested to a larger extent in both in 
vivo gastric and small intestine digestion (Bourlieu et al., 2015; Gallier et al., 2013). It is 
suggested that mother’s milk may protect infants against obesity and this raised a 
considerable concern to formula fed infants. Recently, Oosting et al. (2014) reported 
evidence of long-term effects of early diet of physical structural lipids on fat accumulation 
and metabolism in mice. This confirmation provides support for the emerging consideration 
that dietary lipid structure in early life is related to later-life obesity risk. However, there is 
still limited study on the effect of fat globule size on digestibility (Bourlieu et al., 2015). 
 
3.3 Carbohydrates 
 
Carbohydrates are the second most important source of energy for infant after lipids and 
make up to about 35-55% of the total energy of the infant diet (Fanaro & Vigi, 2012; 
Lebenthal et al., 1983).      
 
Although human milk contains both digestible (lactose) and indigestible carbohydrates 
(oligosaccharides such as gluco-oligosaccharides and maltodextrin-like oligosaccharides) 
(Engfer, Stahl, Finke, Sawatzki, and Daniel, 2000), only digestible carbohydrates are 
permitted to be added to infant formula (Thompkinson & Kharb, 2007). According to 
European Union (2006) only the following carbohydrates can be used in infant formula: 
lactose, maltose, sucrose, maltodextrins, glucose syrup or dried glucose syrup, precooked 
starch and gelatinised starch which are naturally free of gluten. 
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Oligosaccharides 
 
Oligosaccharides are molecules that contain a small number (between 2 to 10) of 
monosaccharide residues connected by glycosidic linkages (International Union of Pure and 
Applied Chemistry, International Union of Biochemistry, 1982). The main difference 
between carbohydrate content in human and cow milk is the amount of oligosaccharides. 
While only humans’ milk is a rich source of oligosaccharides at 5-20 g/L (mature milk), this 
content is at very low level in cow’s milk (Bode, 2012; Engfer et al., 2000; Rudloff and 
Kunz, 1997). Most of the oligosaccharides in human milk are resistant to digestion and 
absorption within the small intestine and act as prebiotics in the infant’s colon (Engfer et al., 
2000; Gnoth, Kunz, Kinne-Saffran, and Rudloff, 2000). Indeed, oligosaccharides promote the 
growth of bifidus flora in the gut (Flack & Shaw, 2003; Rudloff and Kunz, 1997; Goedhart & 
Bindels, 1994) and inhibit bacterial adhesion to epithelial surfaces (Kunz, Rudloff, Baier, 
Klein, and Strobel, 2000) thereby preventing gastrointestinal infection in breast-fed infants. 
 
Based on the good effect on the infant gastrointestinal tract, oligosaccharides were expected 
to supplement in infant formulas. However, with over 100 types of oligosaccharide structures 
present in mother’s milk, this makes it hard to choose the appropriate form of oligosaccharide 
to add to infant formula (Kunz and Rudloff, 1993). Recently, Ben (2008) showed that 
oligosaccharides in mothers’ milk contain 70-90% galactose-oligosaccharides (GOSs) and 
10-30% fructose-oligosaccharides (FOSs) in the first few months of lactation. The author 
further reported that commercial infant formulas have been supplemented with GOSs at 0.2-
0.4 g/100 mL and with FOSs at 0.05-0.1 g/100 mL, although the recommended amount for 
oligosaccharide supplementation are still unavailable (Ben, 2008).  
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Lactose 
 
Lactose is the primary fraction of carbohydrates in milk with around 6-7 g/100 mL in 
mothers’ milk (Bosscher et al., 2000; Jensen, 1995; Bindels, 1992) and around 4.5 g/100 mL 
in cow’s milk (Fox and McSweeney, 1998). Lactose can be used as a sole carbohydrate 
source in infant formula and the amount of lactose supplement should not exceed the 
recommended total carbohydrates for infant formula (Ben, 2008). 
 
Lactose is a slow digestible sugar in the small intestine. The remaining lactose continues to 
be fermented in the large intestine that contributes towards maintaining the acidic pH 5.5-6.0, 
that is beneficial for preventing babies from infection (Thompkinson & Kharb, 2007). 
Lactose also helps increase the absorption of some minerals in the human body such as 
calcium, sodium, and iron (Thompkinson & Kharb, 2007; Koletzko et al., 2005).  
 
Glucose 
 
Only a small amount of glucose is present in both mothers’ and cow’s milk (Whitnah, 1931). 
A very low level of glucose (0.2-0.3 g/L) is added in some commercial infant formulas to 
improve the taste. The glucose addition should be limited to under 2.0 g/100 kcal because 
glucose content offers no bioactivity over other sugar sources and could unnecessarily 
increase the osmolality of formula (Ben, 2008; Thompkinson & Kharb, 2007). According to 
Koletzko et al. (2005) 1g glucose contributes an increase of osmolality by 58 mOsm/kg. So 
far, the ESPGHAN does not recommend adding glucose to infant formulas. 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
Sucrose and fructose 
 
In mothers’ milk, there is currently no available information about sucrose content and 
fructose is absent (Stephen et al., 2012). Sucrose and fructose are much sweeter than lactose. 
This is the reason why infants tend to take higher volumes of formula containing sucrose than 
lactose (Thompkinson & Kharb, 2007). Normally sucrose is supplemented (up 20% of total 
carbohydrate content) in infant formulas based on hydrolysed protein to disguise the bitter 
taste of protein hydrolysates (European Commission, 2003). However, consumption of 
formula supplemented with fructose and sucrose may result in a detrimental impact on 
newborns who have hereditary fructose intolerance (Koletzko et al., 2005; Mock, Perman, 
Thaler, and Morris Jr, 1983). In addition, high intake of fructose could lead to intolerance in 
infants and should be the reason why fructose is not suggested as an additive to infant 
formula (Stephen et al, 2012; Nobigrot, Chasalow, and Lifshitz, 1997). Therefore, 
ESPGHAN recommended sucrose and fructose should not be supplemented in infant 
formulas, especially for babies below 4-6 months (Koletzko et al., 2005). 
 
Maltose, maltodextrins, and corn-starch syrup solids 
 
Maltose, maltodextrin, and corn-starch syrup are the products of corn-starch hydrolysis. 
Maltose, maltodextrin are permitted to be added to infant formulas due to the sufficiency of 
maltase and glucoamylase in infants and they do not raise the osmolality of the formula 
(Fanaro & Vigi, 2012; Koletzko et al., 2005; Lebenthal, 1983). To add in infant formula, 
maltodextrins with 5-9 glucose units should be a good option because human glucoamylase 
has specificity on the chain length of maltodextrin (European Commission, 2003). However, 
chain length of maltodextrins has not been regulated, so current commercial infant formulas 
contained maltodextrins formed from 1-30 glucose units (Coppa et al., 1993). 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
Starches 
 
Only a small amount of starches are recommended as additives to infant formula due to 
insufficient amylase enzymes during infancy (Koletzko et al., 2005). Compared with native 
starches, modified starches are preferred to be used in infant formula because they do not 
retrograde during storage and can prolong the shelf-life of infant formula (Filer 1971). In 
addition, unretrogradation is able to improve the digestibility of modified starches (Filer 
1971). Thus, precooked starch and gelatinised starch (naturally free of gluten) are preferred in 
infant formula (Thompkinson & Kharb, 2007). The recommended amount of these starches 
added in infant formulas is no more than 2 g/100 mL or no more than 30% of total 
carbohydrates (Koletzko et al., 2005).  
 
4. In vitro infant digestion models  
 
In vitro digestion models have been increasingly applied to understand digestibility, structural 
changes, and kinetics of digestion under closely simulated physiological conditions in the 
human gastrointestinal tract (Hur, Lim, Decker, & McClements, 2011). Although in vitro 
models cannot mimic exactly the whole complex digestion process in the human gut, 
especially the composition and subsequent digestive secretion, digestion and absorption, and 
the interaction between the host, the food and micro-bacteria in digestive system (Coles, 
Moughan, and Darragh, 2005), they offer significant advantages compared to in vivo models 
as there are no ethical issues, low cost, and easy sampling accessibility (Sopade and Gidley, 
2009). The commonly applied in vitro digestion models are static and dynamic models that 
are discussed in the sections below. 
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4.1 Static models 
 
Static or biochemical models are defined as the ones, in which the final digestive products 
remain in reaction vessels during the digestion process, and other physical movements like 
shear, mixing, falling of gastric pH, and absorption process are not employed (Wickham, 
Faulks, & Mills, 2009). Hur, Lim, Decker, & McClements (2011) have reviewed many static 
models widely applied in the study of digestibility of food ingredients, bioavailability of 
individual nutrients, allergenicity, antioxidant, and bio-accessibility of toxic metals from soil 
(Daly et al., 2010; Argyri, Birba, Miller, Komaitis, and Kapsokefalou, 2009; Oomen et al., 
2003; Kitabatake & Kinekawa, 1998). The most common model is a conical flask or beaker 
placed in a shaking water bath set at 60-250 rpm and a temperature of 37
°
C similar to human 
body temperature (Fabek, Messerschmidt, Brulport, and Goff, 2014; Hur et al., 2011; Nik, 
Corredig, and Wright, 2010). In terms of gastric pH, static models are not able to recreate the 
dynamic pH changes during the ingestion period. The mean of fasting gastric pH varied 
between 1.5-2 and 3-7 for fed condition (N'Goma, Amara, Dridi, Jannin, Carrière, 2012; 
Charman, Porter, Mithani, and Dressman, 1997, Dressman et al., 1990). Depending upon the 
purpose of research, simulated model for adults chose gastric pH from 1.07 to 2.5 (Pinto et 
al., 2014; Gallier, Tate, and Singh, 2012; Oomen et al., 2003). A more exhaustive 
justification of static in vitro digestion method being close to physiological condition was 
recently produced by Minekus et al. (2014). The international consensus advise the use of pH 
3 for in vitro gastric pH in adults. Hence, for infant simulated digestion, pH in the stomach 
should be higher than that in adults (Figure 1). In addition, the other critical consideration in 
the digestibility study is the concentration of various gastrointestinal fluids like enzymes, bile 
salts and other surfactants. In some recent series of studies on in vitro infant simulated protein 
digestion, 22.75 U/mg of pepsin was added for in vitro stomach digestion (pH 3.0), 0.04 
U/mg protein of α-chymotrypsin and 3.45 U/mg of trypsin for in vitro duodenal digestion (pH 
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6.5) (Dupont et al., 2010a; Dupont et al., 2010b; Dupont et al., 2010c) that are similar to the 
physiological amount found in infants. 
 
 The advantages of static models are their simplicity, low cost and easy cleaning.  
 
4.2 Dynamic models 
 
The main disadvantages of the static models are that they cannot imitate the dynamic 
digestion process taking place in the human gastrointestinal tract that are the gastric 
emptying, peristaltic movements, pH change in the stomach, enzyme and fluid secretion 
during digestion. These difficulties are overcome in a dynamic model. The two popular 
dynamic models are the TIM1 and TIM2. Schematic representation of a static and several 
different dynamic models has been presented in the review article by Guerra et al., 2012. 
 
TIM1 (TNO gastro-intestinal model 1) consists of the gastrointestinal tract with stomach, and 
three other components for the small intestine (duodenum, jejunum, ileum), and the large 
intestine. They were replicated by six vessels controlled by a computer (Minekus, Marteau, 
and Havenaar, 1995). TIM1 takes into account most of the key parameters such as human 
temperature, pH change in the gastric, gastric and pancreatic automatic secretion, gastric 
emptying, gastric and intestinal transit times, peristalsis movements, nutrient absorption in 
the intestine by a dialysis system (Guerra et al., 2012). 
 
 TIM 2 was developed from TIM1 and additionally can imitate the microbiota (Yoo & Chen, 
2006). All these parameters in TIM-1 and TIM-2 are controlled to mimic the digestion in 
human body at different life stages from infant, adults, and elderly (Blanquet et al., 2004). 
TIM-1 was applied to study the behaviour of oral drug dosage under in vitro infant digestion 
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(Blanquet et al., 2004). Blanquet et al. (2004) suggested that TIM-1 is an effective instrument 
to see the changes and availability of drugs in infant (and adult) gastrointestinal conditions.  
 
However, TIM-1 is very expensive for commercial product, and complicated for cleaning and 
handling (Ménard et al., 2014). Ménard et al. (2014) designed a simpler dynamic digestion 
system for infants, which contain two successive chambers for simulated stomach and small 
intestine. Each chamber has a water jacket connected to a water-bath set at 39
0
C to mimic the 
piglet body temperature. The flows of ingested food, digestive enzymes, bile salts and other 
chemicals are controlled by various pumps. The whole system is controlled and monitored by 
a computer program. This dynamic model showed a high correlation for proteolysis between 
in vitro and in vivo models from piglets, but not for the lipolysis (Ménard et al., 2014).  
 
4.3 Commercially available enzymes for in vitro infant digestion study 
 
The commercially available enzymes that are employed in the in vitro digestion studies 
closely resemble the functionality of the digestive enzymes naturally excreted in the 
gastrointestinal tract. The characteristics, and enzyme concentration are the crucial 
parameters for in vitro digestion models. Single and purified enzymes or biological mixture 
has been suggested to be used for standardization among these models and to enable 
comparisons between researchers (Coles, Moughan & Darragh, 2005). The other advantage 
of single enzymes is for forecasting the digestibility of single ingredients in food such as 
protein, starch, or lipids (Boisen & Eggum, 1991). However, the hydrolysis of a specific bond 
relies on the approach of the enzyme to the substrate, so it seems more relevant to the real 
digestion when using the biological mixture of enzymes instead of using individual enzymes 
(Boisen & Eggum, 1991).  
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The physiological activities of digestive enzymes in infants as compared to that for adults are 
summarized in Table 1. It is clear that the activity of most enzymes such as α-amylase, 
pepsin, pancreatic triglyceride lipase are present at very low levels in infants compared to 
their activity in adults, with the exception of gastric lipase and lactase (Armand et al., 1996; 
Armand et al., 1995; Lebenthal et al., 1983). Hence, it is recommended to reduce the 
concentration of digestive enzymes when infant digestion experiments are conducted. For 
instance, Dupont et al. (2010b) reduced the pepsin concentration employed in infant models 
by 8 times; bile salt concentration by 4 times; phospholipid vesicle, trypsin and chymotrypsin 
concentration by 10 times as compared to the corresponding figure for adult models. 
Similarly, Böttger, Etzel, and Lucey (2013) employed one-tenth of the pancreatin used in 
adults for infant digestion models. Recently, Amara et al. (2014) conducted in vitro digestion 
of lipid under infant condition and employed pancreatic lipase that was reduced by 17 times 
compared to adult value (Minekus et al., 2000). 
 
The source of the enzymes used in the digestion studies are as described below: 
 
Proteases 
 
Proteases are comprised of three main enzymes responsible for breakdown of dietary protein 
and peptides into smaller peptides and amino acids. They are pepsin in stomach, trypsin, and 
chymotrypsins in the small intestine (Hur, Lim, Decker, & McClements, 2011). For in vitro 
digestion study, usually pepsin from porcine mucosa is used for gastric proteolysis while 
trypsin and chymotrypsin of porcine or bovine origin are used for protein hydrolysis in the 
intestine. Some researchers also recommend using pancreatic proteases (pancreatin) to mimic 
digestion in the intestinal phase. Pancreatin contains both trypsin, and chymotrypsin as well 
as pancreatic amylase and lipase.   
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All the individual proteases enzymes such as pepsin, trypsin, chymotrypsin or pancreatin 
sourced from mammals are commercially available for in vitro digestion of infants. 
 
Lipases 
 
Gastric lipase is the only lipase involved in the lipolysis of ingested fat in the stomach. Some 
in vitro studies used human gastric juice or purified human gastric lipase (Carrière et al, 
2001; Carrière et al., 2000). However, due to the ethical issues and clinical invasive 
procedures, using human gastric lipase in simulated digestion studies is very limited. Other 
sources of analogue gastric lipase have been applied such as recombinant dog gastric lipase 
(Amara et al., 2014; Fernandez et al., 2013), rabbit gastric lipase (Bourlieu et al., 2015; Vors 
et al., 2012; Capolino et al., 2011) and fungal lipase (Ménard et al., 2014; Mandalari et al., 
2008). Although mammal gastric lipase closely resembles human gastric lipase than fungal 
lipases, its use is restricted because it is not commercially available (Bourlieu et al., 2014). 
Only fungal lipases are commercially available, but fungal lipases expose a different 
specificity compared to human gastric lipase. Fungal lipases has high specificity to sn-1 and 
sn-3 position of triglyceride, whereas mammal gastric lipase prefer only sn-3 (Ménard et al., 
2014). However, no commercial analogue gastric lipase is better than fungal lipase up to now 
(Ménard et al., 2014). 
 
In the small intestine, the lipid enzyme system is more complicated than that in the gastric 
with pancreatic triglyceride lipase (PTL), PLRP 1, 2, phospholipase A2 (PLA2), BSSL or 
cholesterol esterase. Therefore during in vitro lipid digestion, porcine pancreatin is employed 
as the most popular lipases as it contains a mixture of all enzymes secreted by the pancreas 
(Larsen, Sassene, and Müllertz, 2011). However, the chemical composition and enzyme 
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activity in pancreatin rely upon its biological origin, isolation, and purification process. 
Hence, this leads to significant variation in pancreatin from supplier to supplier, and even 
batch to batch (Löhr et al., 2009) though cheaper than purified pancreas lipases. Commercial 
purified pancreas lipases are consistent because of good purification (McClements and Li, 
2010). In addition, lipase derived from bacteria (non-pancreatic lipase source) has also been 
employed (de María, Fernández-Álvaro, ten Kate, and Bargeman, 2009). These non-
pancreatic lipases are highly pure and cheaper than purified pancreas lipases. However, due 
to the bacterial origin, the behaviour of these lipases may be different from those, which has 
been isolated from mammals. The lipase activity also depends on its history, solution, and 
environmental conditions with not very long shelf-life (McClements & Li, 2010).   
 
Pancreatic lipase is dominant in intestinal lipolysis in adults, but this enzyme in infants 
presents at very low levels. In contrast, PLRP 1, 2 and BSSL are the key lipases in duodenal 
lipid digestion in infants (Andersson et al., 2011; Lindquist & Hernell, 2010). However, not 
only are gastric lipase and PLRP 2 not commercially available, the crucial information such 
as concentration of these enzymes in the small intestine of infants has not yet been published. 
It has been suggested that in vitro lipid digestion study for infants is a big challenge because 
to mimic infant lipid digestion, gastric lipase, pancreatic lipase, pancreatic lipase related 
protein 2 and bile salt stimulated lipase should be present (Abrahamse et al., 2012). 
Therefore, there are limited studies on in vitro lipolysis in infants. 
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Carbohydrases 
 
Carbohydrases represent a group of enzymes that help in digestion of starch including α-
amylase in the mouth and α-amylase and glucoamylase in the intestine. Salivary α-amylase 
begins the starch digestion in the mouth. However, due to the very short residence time of 
starch in adults’ mouth, the role of salivary α-amylase in starch digestion in the mouth phase 
is usually ignored (Wolter, Hager, Zannini, and Arendt, 2013; Kaur, Sandhu, and Lim, 2010; 
Wong et al., 2009). In addition, a high portion of salivary amylase is inactivated by acidic 
gastric environment of adults. However, it could remain a minor activity in the poorly 
acidified infants’ stomach (Bourlieu et al., 2014). Therefore, the digestion of starch in the 
stomach of infants should be considered due to the level of α-amylase in the small intestine of 
infants is very low. 
 
Regarding oligosaccharides and disaccharides digestion, the enzymes responsible to digest 
this type of carbohydrates are not secreted into the intestinal fluid. They are bound to the 
intestinal mucosa. Thus, to examine the digestibility of human milk oligosaccharides, Gnoth, 
Kunz, Kinne-Saffran, & Rudloff (2000) and Engfer et al. (2000) employed the intestinal 
brush border membranes from humans and pigs. 
 
5. Conclusions 
 
Although commercially available infant formula has been designed to be close to mothers’ 
milk, there are still differences in composition such as content of β-lactoglobulin, α-
lactalbumin, lactoferrin, αs2-casein, LCPUFAs, oligosaccharides, etc. that could result in 
different composition of formula and its subsequent effect on growth and developmental 
pattern of infants.  
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In the current review, the key differences in infant physiology of the gastrointestinal tract are 
gastric pH, the concentration range of digestive enzymes, and bile salts have been elucidated. 
These basic parameters can be applied to simulate infant digestion of mother’s milk and 
infant formula. In vitro models can be a good alternative to in vivo digestion to obtain data in 
structural changes, rheology, digestibility, and bioavailability of infant foods, although they 
are unable to present exactly the in vivo digestive condition in infants. In addition, simulated 
digestive enzymes such as human gastric lipase, PLRP2, and BSSL have no commercial 
availability and their activities in the infant gastrointestinal tract remain to be elucidated.  
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Table 1 Gastrointestinal enzymes in infants and their activity compared to adults 
  Enzymes Contribution to 
infant digestion 
Activity 
(% of adult) 
Protein digestion   
    Pepsin Low <10 
    Trypsin Adequate 10-60 
    Chymotrypsin Adequate 10-60 
    Elastases Low  NA 
    Carboxypeptidases (A and B) Adequate  NA 
Lipid digestion   NA 
   Gastric lipase  100 
   Pancreatic triglyceride lipase Low 5-10 
   Bile salt dependant lipase Moderate  NA 
   Pancreatic lipase-related to protein 2 Important  NA 
Carbohydrate digestion   NA 
   Salivary α-amylase Moderate 10 
   Pancreatic α-amylase Absent in infants 
< 6 months 
0 
   Glucoamylase High 50-100 
   Lactase High >100 
   Sucrase-Isomaltase High 100 
            NA: not availble  
Adapted from Lebenthal et al.(1983), Hamosh (1996), and Lindquist & Hernell (2010) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
Table 2 Gastric pH of 39 infants (one hour after feeding) 
Age in month Number of 
babies 
pH range pH average 
2-3 8 4.6-5.2 4.7 
4-6 19 3.5-5.5 4.4 
7-9 11 4.0-5.2 4.5 
12 1 3.8 3.8 
Adapted from (Miller, 1942)  
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Table 3 Function of the principle nutrients of human milk in infants 
Nutrients Concentration (g/L) Function 
 Human Cow  
Protein    
Total whey protein 67.3 6.3  
Immunoglobulins 
(slgA, IgM and IgG) 
1.3 0.7 Immune protection 
Lactoferrin 1.5 0.1 Anti-infective, iron carrier 
α-Lactalbumin 1.9 1.2 Ion carrier (Ca2+), part of lactose 
synthase 
Total caseins 2.7 26 Ion carrier, inhibits microbial 
adhesion to mucosal membranes 
Carbohydrate    
Lactose 67 53 Energy source 
Oligosaccharides 0.05-0.2 - Microbial ligands 
Fat 32-36 33  
Triglyceride 97-98% 97% Energy source 
Adapted from Shah (2000), Haug, Hostmark & Harstad, (2007), Lönnerdal and Darragh 
(2011), Landers and Hartmann (2013). 
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Table 4 ESPGHAN recommendation about components in infant formula 
Component Unit Minimum Maximum 
Protein Cow’s milk protein g/100 kcal 1.8 3 
Soy protein isolates g/100 kcal 2.25 3 
Hydrolysed cow’s milk protein g/100 kcal 1.8 3 
Lipids Total fats g/100 kcal 4.4 6.0 
Linoleic acids g/100 kcal 0.3 1.2 
α-linoleic acids mg/100 kcal 50 Not 
specified 
Ratio linoleic acids/α-linoleic 
acids 
 5:1 15:1 
Carbohydrates Total carbohydrates g/100 kcal 9.0 14 
Starches g/100ml  2 
Glucose, sucrose and fructose 
should not be added to infant 
formula  
   
Adapted from Koletzko et al. (2005)  
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Highlights 
 Digestion of macronutrients in infants occurs in gastric and intestinal phases. 
 In vitro models available for infant gastrointestinal digestibility study. 
 Main difference between human and infant GI system is availability of some digestive 
enzymes, their concentration, and less acidic gastric pH. 
 Infant formula and breast milk differ in their composition.  
